19.8 C

The Defense Council added to the expanded նոր new group of patients: BreakingNationalNews Main Website:

A new data-driven risk assessment called COVID-19 has been developed to help identify people who may be at high risk for COVID-19. This risk assessment uses the QCovid® model, developed by the University of Oxford and independently certified by the Office for National Statistics.

It has been used nationally by NHS Digital to help identify an additional group of patients with specific multiple risk factors who, taken together, may be at similar risk to those who are clinically extremely vulnerable to severe outcomes.

As a precautionary measure, This group of patients will now be added to the “List of Protected Patients” (SPL) on the advice of a Chief Physician. It is intended for them to prioritize vaccination if they have not already been vaccinated, լրացուցիչ provide them with additional advice և support, such as prescription deliveries within the Epidemic Delivery Service.

The additional patients identified in this risk assessment will be added to the SPL starting this week by NHS Digital, ranging in age from 19-69. It is expected that the remaining 70+ people will be added to the SPL as soon as possible.

NHS England will contact all patients immediately by email to inform them (where one of their general practitioners is involved) by email. They will be advised to carefully follow the instructions of the Government in the high-risk group, which currently includes protection.

Up to 1.7 million patients were found in the new group. Those in this group over the age of 70 will already be invited for vaccination, and 820,000 adults between the ages of 19 and 69 will now be vaccinated.

Read further clinical information on COVID-19 Population Risk Assessment և Additions to SPL

Read the news from the Department of Health and Social Welfare

In addition, the Department of Health and Social Welfare announced this Government’s Defense Council և Assistance is extended in the country until March 31, 2021,


Please enter your comment!
Please enter your name here